Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Research

• Publication date

  2011-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-11-0573PMID 21852386
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

  2011cited by this paper
• Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

  2010cited by this paper
• Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis.

  2010cited by this paper
• Differences in tumor regulatory T-cell localization and activation status impact patient outcome.

  2009cited by this paper
• The adenylyl cyclase-cAMP system suppresses TARC/CCL17 and MDC/CCL22 production through p38 MAPK and NF-kappaB in HaCaT keratinocytes.

  2009cited by this paper
• NK-Dependent Increases in CCL22 Secretion Selectively Recruits Regulatory T Cells to the Tumor Microenvironment1

  2009cited by this paper
• Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

  2009cited by this paper
• Regulatory lymphocytes and intestinal inflammation.

  2009cited by this paper
• Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis.

  2009cited by this paper
• CCL22 Recruits CD4-positive CD25-positive Regulatory T Cells into Malignant Pleural Effusion

  2009cited by this paper
• Natural killer cells: detectors of stress.

  2008cited by this paper
• Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin’s lymphoma

  2008cited by this paper
• Dynamic Modulation of CCR7 Expression and Function on Naive T Lymphocytes In Vivo1

  2008cited by this paper
• Comparison of Level of NKG2D Ligands between Normal and Tumor Tissue Using Multiplex RT-PCR

  2007cited by this paper
• Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease

  2007cited by this paper
• Preferential migration of regulatory T cells mediated by gliomasecreted chemokines can be blocked with chemotherapy

  2007cited by this paper
• CCR4-dependent regulatory T cell function in inflammatory bowel disease

  2007cited by this paper
• Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy

  2007cited by this paper
• Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer

  2007cited by this paper
• Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

  2007cited by this paper
• Upregulation of MICA on high-grade invasive operable breast carcinoma.

  2007cited by this paper
• Control of NK cell functions by CD4+CD25+ regulatory T cells

  2007cited by this paper
• The number of regulatory T cells in prostate cancer is associated with the androgen receptor and hypoxia‐inducible factor (HIF)‐2α but not HIF‐1α

  2007cited by this paper
• Inhibition of T helper 2 chemokine production by narrowband ultraviolet B in cultured keratinocytes

  2007cited by this paper
• Opposite Fate of Endocytosed CCR7 and Its Ligands: Recycling versus Degradation1

  2006cited by this paper
• Tumor-Infiltrating Cytotoxic T Cells but not Regulatory T Cells Predict Outcome in Anal Squamous Cell Carcinoma

  2006cited by this paper
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

  2006cited by this paper
• Chemokine expression is dysregulated in the endometrium of women using progestin-only contraceptives and correlates to elevated recruitment of distinct leukocyte populations.

  2005cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer

  2004cited by this paper
• Breast carcinoma cells promote the differentiation of CD34+ progenitors towards 2 different subpopulations of dendritic cells with CD1ahighCD86−Langerin‐ and CD1a+CD86+Langerin+ phenotypes

  2004cited by this paper
• Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells

  2004cited by this paper
• Reciprocal regulation of thymus and activation-regulated chemokine/macrophage-derived chemokine production by interleukin (IL)-4/IL-13 and interferon-gamma in HaCaT keratinocytes is mediated by alternations in E-cadherin distribution.

  2004cited by this paper
• ELR+ CXC chemokines in human milk.

  2003cited by this paper
• Differential expression of thymus- and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung.

  2003cited by this paper
• Detection of interferon‐γ‐inducible chemokines in human milk

  2003cited by this paper
• Detection of interferon-gamma-inducible chemokines in human milk.

  2003cited by this paper
• Both IL-4 and IL-13 inhibit the TNF-α and IFN-γ enhanced MDC production in a human keratinocyte cell line, HaCaT cells

  2003cited by this paper
• Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells.

  2003cited by this paper
• IL-10 augments the IFN-γ and TNF-α induced TARC production in HaCaT cells: A possible mechanism in the inflammatory reaction of atopic dermatitis

  2001cited by this paper
• IL-10 augments the IFN-gamma and TNF-alpha induced TARC production in HaCaT cells: a possible mechanism in the inflammatory reaction of atopic dermatitis.

  2001cited by this paper
• Production of MDC/CCL22 by human intestinal epithelial cells.

  2001cited by this paper
• Dendritic cells as a major source of macrophage‐derived chemokine/CCL22 in vitro and in vivo

  2001cited by this paper
• Inducible Expression of a Th2-Type CC Chemokine Thymus- and Activation-Regulated Chemokine by Human Bronchial Epithelial Cells1

  2000cited by this paper
• The role of chemokine receptors in primary, effector, and memory immune responses.

  2000cited by this paper
• Cc Chemokine Receptor (Ccr)3/Eotaxin Is Followed by Ccr4/Monocyte-Derived Chemokine in Mediating Pulmonary T Helper Lymphocyte Type 2 Recruitment after Serial Antigen Challenge in Vivo

  2000cited by this paper
• STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13.

  1998cited by this paper
• Macrophage-derived Chemokine Is a Functional Ligand for the CC Chemokine Receptor 4*

  1998cited by this paper
• Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s

  1998cited by this paper
• Expression of macrophage‐derived chemokine (MDC) mRNA in macrophages is enhanced by interleukin‐1 β, tumor necrosis factor α, and lipopolysaccharide

  1998cited by this paper
• Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells

  1997cited by this paper
• Interferon gamma inhibits interleukin 10 production by monocytes

  1993cited by this paper

• Tumor cells upregulate CCL22 in a STING-dependent manner in response to paracrine factors released by STING-activated myeloid cells and type I interferons

  2025cites this paper
• Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially control regulatory T cell phenotype and function via CXCL9 and CCL22

  2025cites this paper
• Regulatory T cell and endothelial cell crosstalk

  2025cites this paper
• A new concept for oncogenic analysis of tumor microenvironment and chemokines and non-coding RNAs in breast cancer

  2025cites this paper
• The Role of Artificial Intelligence in Early Tumor Detection: An XGBoost Risk Assessment Model for Egyptian Patients

  2025cites this paper
• Unraveling the breast cancer tumor microenvironment: crucial factors influencing natural killer cell function and therapeutic strategies

  2025cites this paper
• Multi-omics dissection of tumor microenvironment-mediated drug resistance: mechanisms and therapeutic reprogramming

  2025cites this paper
• Regulatory T Cells in Tumor Microenvironment: Therapeutic Approaches and Clinical Implications

  2025cites this paper
• Context-dependent impact of type I interferon signaling in cancer

  2025cites this paper
• Tumor organoids targeted by receptor-engineered immune cells: A promising approach for advancing cancer immunotherapy.

  2025cites this paper
• Regulatory T Cells in Colon Cancer: Implications for Pathogenesis, Prognosis and Emerging Therapeutic Strategies

  2025cites this paper
• Immunomodulatory effects of Diospyros peregrina fruit preparation (DFP) in non-small cell lung cancer (NSCLC) by utilizing dendritic cell-mediated antigen presentation and T helper (TH) cell differentiation

  2024cites this paper
• Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer

  2024cites this paper
• Targeting tumor-infiltrating tregs for improved antitumor responses

  2024cites this paper
• CCL22 as an independent prognostic factor in endometrial cancer patients

  2024influential citation
• Promising preclinical models for lung cancer research—lung cancer organoids: a narrative review

  2024cites this paper
• Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA

  2023cites this paper
• Biomarkers and experimental models for cancer immunology investigation

  2023cites this paper
• The tautomerase activity of tumor exosomal MIF promotes pancreatic cancer progression by modulating MDSC differentiation.

  2023cites this paper
• Tumor microenvironment signaling and therapeutics in cancer progression

  2023cites this paper
• Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling

  2023cites this paper
• Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal

  2023cites this paper
• Role of natural killer and B cell interaction in inducing pathogen specific immune responses

  2023cites this paper
• Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2

  2022cites this paper
• Low-dose cyclophosphamide combined with IL-2 inhibits tumor growth by decreasing regulatory T cells and increasing CD8+ T cells and natural killer cells in mice.

  2022cites this paper
• Regulatory T Cells but Not Tumour-Infiltrating Lymphocytes Correlate with Tumour Invasion Depth in Basal Cell Carcinoma

  2022cites this paper
• Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics

  2022cites this paper
• Interferon regulatory factor 3 upregulates the Treg recruitment factor CCL22 in response to double-stranded DNA in cancer cells

  2022cites this paper
• Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers

  2022cites this paper
• Potential of chimeric antigen receptor (CAR)‐redirected immune cells in breast cancer therapies: Recent advances

  2022cites this paper
• CCL22-Polarized TAMs to M2a Macrophages in Cervical Cancer In Vitro Model

  2022cites this paper
• Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80+ PDL1−)‐pDC subset negatively correlated with clinical outcomes in melanoma patients

  2022cites this paper
• Key chemokines direct migration of immune cells in solid tumors

  2021cites this paper
• Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer.

  2021cites this paper
• Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?

  2021cites this paper
• Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application

  2021cites this paper
• Inflammation and tumor progression: signaling pathways and targeted intervention

  2021cites this paper
• Tumor resident regulatory T cells.

  2021cites this paper
• RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming

  2021cites this paper
• Tumor-infiltrating T-regulatory cells adapt to altered metabolism to promote tumor-immune escape

  2021cites this paper
• Tumour‐immune microenvironment in duodenal‐type follicular lymphoma

  2020cites this paper
• CCL22 Signaling in the Tumor Environment.

  2020cites this paper
• Diminished CD68+ cancer-associated fibroblasts subset induces Tregs infiltration and predicts poor prognosis of oral squamous cell carcinoma patients.

  2020cites this paper
• Infiltrating Treg Cells Suppress Anti-Tumor Immunity in Tumor Microenvironment

  2020cites this paper
• Tumors establish resistance to immunotherapy by regulating Treg recruitment via CCR4

  2020cites this paper
• Chemokine biology on immune checkpoint-targeted therapies.

  2020cites this paper
• Organoid Models of Tumor Immunology

  2020cites this paper
• Regulatory T Cells in Cancer

  2020cites this paper
• Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate.

  2019cites this paper
• Cancer‐associated fibroblast‐derived interleukin‐1β activates protumor C‐C motif chemokine ligand 22 signaling in head and neck cancer

  2019cites this paper
• Regulatory T cells as therapeutic targets and mediators

  2019cites this paper
• Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches

  2019cites this paper
• Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells

  2019cites this paper
• Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

  2019cites this paper
• TRANSCRIPTOME ANALYSIS OF TUMOR INFILTRATING T REGULATORY CELLS UNVEILS SPECIFIC CODING AND NON CODING GENE SIGNATURE

  2019cites this paper
• Plasma Factors for the Differentiation of Hodgkin’s Lymphoma and Diffused Large B Cell Lymphoma and for Monitoring Remission

  2019cites this paper
• CCL1 is a major regulatory T cell attracting factor in human breast cancer

  2018cites this paper
• The role of regulatory T cells in pathogenesis and therapy of human papillomavirus-related diseases, especially in cancer.

  2018cites this paper
• Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq

  2018cites this paper
• T cell-inflamed phenotype and increased Foxp3 expression in infiltrating T-cells of mismatch-repair deficient endometrial cancers

  2018cites this paper
• Strategies to Reduce Intratumoral Regulatory T Cells

  2018cites this paper
• Plasmacytoid DC/Regulatory T Cell Interactions at the Center of an Immunosuppressive Network in Breast and Ovarian Tumors

  2018cites this paper
• Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.

  2017cites this paper
• Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.

  2017cites this paper
• Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin

  2017cites this paper
• C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy.

  2017cites this paper
• Regulatory T cells in cancer immunotherapy

  2016cites this paper
• Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting

  2016cites this paper
• Organoids as Models for Neoplastic Transformation.

  2016cites this paper
• Cancer and Chemokines.

  2016cites this paper
• Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells

  2016cites this paper
• FOXP3+ Cells Recruited by CCL22 into Breast Cancer Correlates with Less Tumor Nodal Infiltration.

  2016cites this paper
• Understanding dendritic cell immunotherapy in ovarian cancer

  2016cites this paper
• CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment

  2016cites this paper
• Emerging insights into natural killer cells in human peripheral tissues

  2016cites this paper
• Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis

  2016cites this paper
• The effect of Tamoxifen and Fulvestrant on pro-inflammatory markers in oestrogen receptor positive breast cancer

  2016cites this paper
• Role of regulatory T cells and associated chemokines in human gynecological tumors

  2016cites this paper
• Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer.

  2016cites this paper
• Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients

  2015cites this paper
• Immune effects of targeted radiation therapy for cancer.

  2015cites this paper
• Nanoparticulate immunotherapy for cancer.

  2015cites this paper
• Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism

  2015cites this paper
• TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth

  2015cites this paper
• Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression.

  2015cites this paper
• O microambiente supressor no câncer: efeitos locais e sistêmicos em monócitos de pacientes.

  2015cites this paper
• Association of serum cytokines with colorectal polyp number and type in adult males

  2015cites this paper
• Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay

  2015cites this paper
• Anticorps humanisés anti-récepteur de la chimiokine cc4 (ccr4) et leurs procédés d'utilisation

  2015cites this paper
• Control of Regulatory T Cell Migration, Function, and Homeostasis

  2015cites this paper
• Disequilibrium of BMP2 Levels in the Breast Stem Cell Niche Launches Epithelial Transformation by Overamplifying BMPR1B Cell Response

  2015cites this paper
• Regulatory T cells in cancer immunotherapy.

  2014cites this paper
• Tumorzell-induzierte Hochregulation des Chemokins CCL22 in Immunzellen

  2014cites this paper
• Lymphocytes T CD4 et immunité anti-tumorale naturelle : impact de la chimiothérapie, émergence de lymphocytes T CD4 cytotoxiques

  2014influential citation
• TH1 AND TH2 CYTOKINE GENE EXPRESSION IN THE PERIPHERAL BLOOD OF BREAST CANCER PATIENTS COMPARED TO CONTROLS

  2014cites this paper
• miR141–CXCL1–CXCR2 Signaling–Induced Treg Recruitment Regulates Metastases and Survival of Non–Small Cell Lung Cancer

  2014cites this paper
• CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph

  2014cites this paper
• The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment

  2014cites this paper
• LymphSecondary Lymphoid Organs via Afferent Neoplastic Solid Tissues and Recirculate to NK Cells Are Abundant in Both Healthy and Noncytotoxic Human low Perforin bright CD56

  2014cites this paper
• miR-141-CXCL1-CXCR2 signaling-induced Treg cells recruitment regulates metastases and survival of non-small cell lung cancer

  2014cites this paper